Previous close | 8.96 |
Open | 8.81 |
Bid | 8.84 x 500 |
Ask | 8.87 x 500 |
Day's range | 8.65 - 9.00 |
52-week range | 4.52 - 16.62 |
Volume | |
Avg. volume | 2,776,554 |
Market cap | 2.233B |
Beta (5Y monthly) | 0.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Strategy” investor letter, which can be downloaded here. As a late-year rally was fueled by confidence about an economic soft landing, a dovish flip by the Fed, and broader market performance, mid-cap stocks saw strong gains. Due to an inconstant industrial and consumer discretionary […]
The investors in Maravai LifeSciences Holdings, Inc. 's ( NASDAQ:MRVI ) will be rubbing their hands together with glee...